Sales forecast Novartis blockbuster drugs 2028

Sales forecast of select Novartis blockbuster drugs worldwide in 2028 (in million U.S. dollars)

Sales forecast of select blockbuster drugs by Novartis worldwide 2028

Last update:

Oct 6, 2022

Author:

��ƽ�� Research Department

Region:

Worldwide

Survey time period:

From 01/01/2028 to 31/12/2028

In 2028, Novartis blockbuster drug Cosentyx is projected to generate some 7.1 billion U.S. dollars in sales worldwide, while drug Entrestro is forecasted to generate around 6.3 billion U.S. dollars globally in the same year. This statistic illustrates the sales forecast of select of Novartis' blockbuster drugs worldwide in 2028.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Sales forecast of select Novartis blockbuster drugs worldwide in 2028 (in million U.S. dollars)

Get in touch with us for additional information

��ƽ��